Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion type Assertion NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_head.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion description "[In the current study using fluorescence in situ hybridization (FISH), we identified the TMPRSS2:ERG rearrangements in 49.2% of 118 primary prostate cancers and 41.2% of 18 hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion evidence source_evidence_literature NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion SIO_000772 16951139 NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion wasDerivedFrom befree-20140225 NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.
- NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_assertion wasGeneratedBy ECO_0000203 NP427805.RAJeO49_YEH6TGZjIKHRmlhby7CPoUkef7dfa-4k7CM8g130_provenance.